MedTrace Logo

Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression

NCT00608998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-03-22

No results posted yet for this study

Summary

The aim of this study is to appreciate the influence of renal failure progression on vasculopathy (coronary calcifications and left ventricular hypertrophy) and cardiovascular risk factors.

Conditions

  • Chronic Renal Failure

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Bernard CANAUD, Pr · CHU Lapeyronie Montpellier France

  • Jean-Paul CRISTOL, Pr · CHU Lapeyronie Montpellier France

  • Hélène VERNHET, Pr · CHU Arnaud de Villeneuve Montpellier France

  • Kada KLOUCHE, Dr · CHU Lapeyronie Montpellier France

  • Hélène LERAY-MORAGUES, Dr · CHU Lapeyronie Montpellier France

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00608998 on ClinicalTrials.gov